SYRE
Price
$16.38
Change
+$0.77 (+4.93%)
Updated
Sep 26, 01:26 PM (EDT)
Capitalization
942.86M
41 days until earnings call
VTYX
Price
$2.85
Change
+$0.16 (+5.95%)
Updated
Sep 26, 02:02 PM (EDT)
Capitalization
191.82M
47 days until earnings call
Interact to see
Advertisement

SYRE vs VTYX

Header iconSYRE vs VTYX Comparison
Open Charts SYRE vs VTYXBanner chart's image
Spyre Therapeutics
Price$16.38
Change+$0.77 (+4.93%)
Volume$180
Capitalization942.86M
Ventyx Biosciences
Price$2.85
Change+$0.16 (+5.95%)
Volume$650
Capitalization191.82M
SYRE vs VTYX Comparison Chart in %
Loading...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SYRE vs. VTYX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SYRE is a Buy and VTYX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (SYRE: $15.61 vs. VTYX: $2.69)
Brand notoriety: SYRE and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SYRE: 191% vs. VTYX: 77%
Market capitalization -- SYRE: $942.86M vs. VTYX: $191.82M
SYRE [@Biotechnology] is valued at $942.86M. VTYX’s [@Biotechnology] market capitalization is $191.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SYRE’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • SYRE’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, VTYX is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SYRE’s TA Score shows that 5 TA indicator(s) are bullish while VTYX’s TA Score has 4 bullish TA indicator(s).

  • SYRE’s TA Score: 5 bullish, 5 bearish.
  • VTYX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than VTYX.

Price Growth

SYRE (@Biotechnology) experienced а +1.89% price change this week, while VTYX (@Biotechnology) price change was +12.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

SYRE is expected to report earnings on Nov 06, 2025.

VTYX is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($943M) has a higher market cap than VTYX($192M). VTYX YTD gains are higher at: 22.831 vs. SYRE (-32.947). VTYX has higher annual earnings (EBITDA): -129.1M vs. SYRE (-222.15M). SYRE has more cash in the bank: 527M vs. VTYX (209M). SYRE has less debt than VTYX: SYRE (0) vs VTYX (10.3M). SYRE (0) and VTYX (0) have equivalent revenues.
SYREVTYXSYRE / VTYX
Capitalization943M192M491%
EBITDA-222.15M-129.1M172%
Gain YTD-32.94722.831-144%
P/E Ratio1.72N/A-
Revenue00-
Total Cash527M209M252%
Total Debt010.3M-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
34

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SYREVTYX
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 23 days ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYEUX120.06N/A
N/A
Rydex Europe 1.25x Strategy H
MUTHX26.78N/A
N/A
Franklin Mutual Shares Z
GTSAX30.55N/A
N/A
Invesco Small Cap Growth A
LCRIX24.07N/A
N/A
Leuthold Core Investment Institutional
LFGVX43.91N/A
N/A
Lord Abbett Focused Growth R6

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with CGON. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
-8.18%
CGON - SYRE
59%
Loosely correlated
-0.55%
IDYA - SYRE
59%
Loosely correlated
+0.08%
XNCR - SYRE
57%
Loosely correlated
-1.34%
CRNX - SYRE
56%
Loosely correlated
+2.02%
BEAM - SYRE
56%
Loosely correlated
-2.12%
More